Investing Profile

René Kuijten

InvestorVC
Partner, Head of EQT Life Sciences
eqtgroup.com/about/people/ren...Amsterdam, Netherlands
Photo of René Kuijten, Partner at EQT Life Sciences
Your Intro Paths to René Kuijten

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find René Kuijten on

cb
Current Investing Position
EQT Life Sciences Partner
Investment Range
$11.0M - $65.0M
Sweet Spot
$25.0M
Investments On Record
6
Current Fund Size
€260M

René Kuijten is on these Sector & Stage Rankings

René Kuijten's Investments On Record (4)

CompanyStageDateRound SizeTotal Raised
Artios Pharma
Series DNov 2025$120M
Series CJul 2021$150M
Series BAug 2018$83M
$380M
Co-investors: Hakan Goker (M Ventures (Merck)), Florian Müllershausen (Novartis Venture Fund), Raphael Wisniewski (Andera Partners), Barbara Dalton (Pfizer Venture Investments), Nikola Trbovic (Pfizer Venture Investments), Jake Simson (RA Capital)
Neuravi
Series BJun 2015$22M
$22M
Co-investors: Anne Portwich (EQT Life Sciences)
BMEYE
Series BOct 2009$9M
$9M
Co-investors: Thom Rasche (Earlybird Health Tech)
Syntaxin
Series BOct 2007$32M
$71M
Co-investors: Genghis Lloyd-Harris (Abingworth), Deborah Harland (SR One)

Founders who looked at René Kuijten's profile also looked at these Scouts & Angels

Photo of Christopher Priebe, Angel

Photo of Justin Waldron, Angel

Photo of Errol Damelin, Angel

Photo of Brad Holden, Managing Partner